Stryker invests USD 400 million: Stryker stock sits 18.82 percent below high

Published on 10/23/2026 at 11:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stryker's robotics deal includes an option to buy CMR Surgical. Stryker stock costs EUR 273.10, 0.87 percent below its Xetra close.

Robotics expansion and reporting dates

Stryker committed USD 400 million to CMR Surgical on October 12, 2026.
Second-quarter revenue reached USD 6.59 billion, up 9.40 percent year over year.
Stryker stock trades at EUR 273.10 at 11:11 a.m. CEST at Lang & Schwarz on October 23, 2026, 0.87 percent below the Xetra close of October 22, 2026.
Third-quarter results are scheduled for October 29, 2026, after the US market close.

Pop-Art-Comic zeigt Chirurgen mit robotergestütztem OP-System in leuchtenden Farben — Pop-Art-Comic-Illustration einer farbenfrohen Roboterchirurgie-Szene verbildlicht anschaulich das Geschäftsfeld von Stryker Corp. US8636671013 heute, Illustration mit AI erstellt.

Stryker Corporation (ISIN US8636671013) committed approximately USD 400 million to CMR Surgical on October 12, 2026, gaining an exclusive option to acquire the British robotics company. The alliance also makes Stryker the exclusive US sales agent for CMR's Versius surgical robotics portfolio, according to GlobeNewswire. The move gives Stryker a new growth angle while leaving CMR responsible for development outside the United States.

Robotics entry adds a growth option

The investment is material against Stryker's latest operating base, but the deal does not yet include a full acquisition. Stryker can eventually acquire 100 percent of CMR's outstanding equity, subject to the agreement's terms and regulatory approvals.

The financial backdrop was supportive before the alliance. In the second quarter of 2026, revenue rose 9.40 percent year over year to USD 6.59 billion, while adjusted earnings per share reached USD 3.69 against a USD 3.49 consensus estimate, according to MarketBeat. Fiscal 2026 earnings per share guidance stands at USD 14.95 to USD 15.10.

What does the deal mean for growth?

Management is entering soft-tissue robotics through commercial access rather than an immediate takeover. That structure limits the initial commitment to USD 400 million while giving Stryker a route to broader ownership if Versius gains traction with US hospitals and ambulatory surgery centers.

Three dated Stryker milestones

On July 30, 2026, Stryker reported USD 6.59 billion in second-quarter revenue and USD 3.69 in earnings per share, as MarketBeat reported. On October 6, 2026, Stryker named Spencer Stiles as incoming chief executive officer effective January 1, 2027, according to FinancialFilings. On October 12, 2026, the company announced the USD 400 million CMR alliance.

Next dates for Stryker

Stryker is scheduled to discuss third-quarter 2026 results on October 29, 2026, at 4:30 p.m. ET, according to its investor calendar. The quarterly dividend is scheduled for payment on October 30, 2026, according to MarketBeat.

Stock sits below its yearly high

Stryker stock was trading at EUR 273.10 at Lang & Schwarz on October 23, 2026, at 11:11 a.m. CEST, down 0.87 percent versus the Xetra close of October 22, 2026 at EUR 275.50. The euro quote is 18.82 percent below the 52-week high of EUR 336.40, while the 52-week low is EUR 210.60.

The further course of trading is shown by the continuously updated real-time quote of Stryker stock.